Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,621 | 112 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $259.90 | 21 | $0 (2021) |
| Abbott Laboratories | $177.66 | 2 | $0 (2024) |
| Amarin Pharma Inc. | $171.63 | 15 | $0 (2021) |
| Novo Nordisk Inc | $165.93 | 18 | $0 (2021) |
| Biohaven Pharmaceuticals, Inc. | $101.81 | 5 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $94.56 | 6 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $86.96 | 7 | $0 (2021) |
| Astellas Pharma US Inc | $74.96 | 5 | $0 (2021) |
| UPSHER-SMITH LABORATORIES LLC | $57.55 | 4 | $0 (2021) |
| PFIZER INC. | $44.64 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $88.24 | 1 | Abbott Laboratories ($88.24) |
| 2022 | $107.16 | 2 | Abbott Laboratories ($89.42) |
| 2021 | $1,426 | 109 | AbbVie Inc. ($259.90) |
All Payment Transactions
112 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/01/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $88.24 | General |
| Category: Diabetes Care | ||||||
| 09/19/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $89.42 | General |
| Category: Diabetes Care | ||||||
| 02/10/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: PRIMARY CARE | ||||||
| 11/30/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $2.19 | General |
| Category: Cardiovascular | ||||||
| 11/22/2021 | PFIZER INC. | PREVNAR 13 (Biological), TRUMENBA, PREVNAR 20 | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: VACCINES | ||||||
| 11/01/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.84 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2021 | Organon LLC | — | Food and Beverage | In-kind items and services | $10.63 | General |
| 10/20/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: NEUROSCIENCE | ||||||
| 10/13/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: Cardiovascular | ||||||
| 10/07/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/04/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Diabetes | ||||||
| 10/04/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: RESPIRATORY | ||||||
| 10/04/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $1.46 | General |
| Category: Diabetes | ||||||
| 10/01/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: NEUROSCIENCE | ||||||
| 09/22/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Cardiovascular | ||||||
| 09/20/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: UROLOGY | ||||||
| 09/15/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: Diabetes | ||||||
| 09/13/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $1.82 | General |
| Category: Diabetes | ||||||
| 09/10/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: NEUROSCIENCE | ||||||
| 09/02/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/27/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.18 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: Diabetes | ||||||
| 08/26/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $1.97 | General |
| Category: Diabetes | ||||||
| 08/25/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 3 | 85 | 115 | $16,385 | $6,337 |
| 2020 | 6 | 242 | 328 | $39,905 | $17,676 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 38 | 53 | $9,275 | $3,424 | 36.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 36 | 51 | $6,375 | $2,197 | 34.5% |
| 90682 | Vaccine for influenza derived from dna for injection into muscle, quadrivalent, preservative and antibiotic free | Office | 2021 | 11 | 11 | $735.00 | $716.04 | 97.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 74 | 156 | $23,400 | $9,306 | 39.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 52 | 52 | $11,405 | $5,040 | 44.2% |
| 90682 | Vaccine for influenza for injection into muscle | Office | 2020 | 19 | 20 | $1,275 | $1,204 | 94.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 21 | 24 | $2,400 | $957.99 | 39.9% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2020 | 57 | 57 | $855.00 | $859.11 | 100.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 19 | 19 | $570.00 | $308.05 | 54.0% |
About David Badham, PAC
David Badham, PAC is a Physician Assistant healthcare provider based in Bountiful, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2012. The National Provider Identifier (NPI) number assigned to this provider is 1073875126.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Badham, PAC has received a total of $1,621 in payments from pharmaceutical and medical device companies, with $88.24 received in 2024. These payments were reported across 112 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($1,621).
As a Medicare-enrolled provider, Badham has provided services to 327 Medicare beneficiaries, totaling 443 services with total Medicare billing of $24,013. Data is available for 2 years (2020–2021), covering 9 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Bountiful, UT
- Active Since 06/14/2012
- Last Updated 07/09/2013
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1073875126
Products in Payments
- Vascepa (Drug) $171.63
- VRAYLAR (Drug) $150.01
- Ozempic (Drug) $149.28
- NURTEC ODT (Drug) $119.55
- FREESTYLE LIBRE 2 (Device) $89.42
- FREESTYLE LIBRE 3 (Device) $88.24
- MYRBETRIQ (Drug) $74.96
- FARXIGA (Drug) $60.73
- TOSYMRA (Drug) $57.55
- UBRELVY (Drug) $53.18
- BELSOMRA (Drug) $50.59
- TRADJENTA (Drug) $43.13
- WATCHMAN (Device) $38.25
- GARDASIL 9 (Biological) $31.40
- LINZESS (Drug) $30.46
- SUNOSI (Drug) $29.96
- SOLIQUA 100/33 (Biological) $27.91
- TRELEGY ELLIPTA (Drug) $26.64
- HETLIOZ (Drug) $26.57
- CREON (Drug) $26.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Bountiful
G Ellis, Pa-C, PA-C
Physician Assistant — Payments: $4,665
Christine Packard, Pa-C, PA-C
Physician Assistant — Payments: $3,571
Heather Swann
Physician Assistant — Payments: $2,480
Todd Lythgoe, Pa-C, PA-C
Physician Assistant — Payments: $1,601
Brandi Harris
Physician Assistant — Payments: $1,295
Natalie Parkin, Pac, PAC
Physician Assistant — Payments: $609.82